Black specks detected during campaign changeover – FDA inspection observation risk
Addressing Black Specks Detected During Campaign Changeover: A Comprehensive Investigation Approach Manufacturers in the pharmaceutical industry periodically encounter unexpected results that can lead to regulatory scrutiny and operational disruptions. One…